Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company developing a novel therapy to restore smell and flavor function. The chronic loss of smell and flavor is a condition affecting at least 5% of the U.S. population with a similar incidence in Europe and Asia. Influenza, allergic rhinitis and traumatic brain injury are commonly known causes of chronic smell and flavor loss. The condition is now recognized as a widely prevalent long-term condition experienced by many patients who have recovered from COVID-19.
Rick has more than 35 years of management experience in the healthcare industry. He has previously founded five healthcare companies, recapitalized/restructured two others and built significant value for shareholders. Rick is also a member of the Executive Committee and the Board of Directors for the Medical Device Innovation Consortium and Vice Chairman of The Mullings Group.Read More
Founder and Director of The Taste and Smell Clinic, Washington DC, Dr. Henkin has spent the last 40 years devoted to the advancement of the diagnosis and treatment of taste and smell disorders as evidenced by over 1000 peer reviewed publications on the subject. Prior to the Taste and Smell Clinic, Dr. Henkin was a scientist at the NIH and a Professor at Georgetown University.
Ron Kuppersmith, MD, MBA, FACS, practices in College Station, Texas and is a Professor of Surgery at the Texas A&M Health Science Center College of Medicine. He has previously served as President of the American Academy of Otolaryngology-Head and Neck Surgery and President of the Texas Association of Otolaryngology.
Former FDA reviewer (6 years), over 30 years of experience in pharma, with over 10 years of regulatory drug development experience in working with Central Nervous System compounds.
At Cyrano Therapeutics, we are committed to developing a proven therapy for long-term smell and flavor loss. For more information about joining our future clinical trials please contact us.